STOCK TITAN

Forian Inc. - FORA STOCK NEWS

Welcome to our dedicated news page for Forian (Ticker: FORA), a resource for investors and traders seeking the latest updates and insights on Forian.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Forian's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Forian's position in the market.

Rhea-AI Summary
Forian Inc. announces the passing of Director Martin J. Wygod, a healthcare entrepreneur and philanthropist. Marty was a key figure in the medical and healthcare information industry, contributing to companies like WebMD and Medco. His legacy includes improving medical decisions, lowering healthcare costs, and generating value for shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.53%
Tags
none
-
Rhea-AI Summary
Forian Inc. (FORA) reported a 25% increase in revenue for the full year 2023, with Adjusted EBITDA reaching $2.3 million. The company divested BioTrack, focusing on healthcare and life sciences, achieving positive Adjusted EBITDA ahead of schedule. Forian also expanded data sources, repurchased shares, and provided a positive outlook for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.86%
Tags
-
Rhea-AI Summary
Forian Inc. (FORA) will announce its Q4 and full year 2023 financial results on March 28, 2024. A conference call and webcast will be held to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.87%
Tags
Rhea-AI Summary
FORA - Forian Inc. Reports 24% Year-Over-Year Revenue Growth in Q3 2023, Expands Data Factory for Enhanced Insights
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
-
Rhea-AI Summary
Forian Inc. (Nasdaq:FORA) will announce its third quarter 2023 financial results on November 9, 2023, after the market closes. The Company will host a conference call and webcast at 5:00 p.m. (ET) to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2%
Tags
-
Rhea-AI Summary
Forian Inc. (Nasdaq:FORA) announces that its CEO and CFO will attend ROTH MKM’s 12th annual Technology Event on November 15, 2023, in New York City. The event will allow investors to meet with management from 60 public companies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.93%
Tags
conferences
News
Rhea-AI Summary
Forian Inc. repurchased 1,604,676 shares of Forian common stock at $2.15 per share for a total of $3.45 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.41%
Tags
buyback
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.54%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.86%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Forian Inc.

Nasdaq:FORA

FORA Rankings

FORA Stock Data

82.50M
16.22M
49.38%
13.47%
0.53%
Data Processing, Hosting, and Related Services
Information
Link
US
Denver

About FORA

forian provides a unique suite of saas solutions, data management capabilities and proprietary data and analytics to optimize and measure operational, clinical and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments, as well as cannabis dispensaries, manufacturers, cultivators and regulators.